. 2016 Mar 8;11(3):e0150990. doi: 10.1371/journal.pone.0150990

Table 2. Statin-associated adverse outcomes in Chinese and non-Chinese (referent).

	Number of Events (rate per 10,000 person-years)		Hazard Ratio (95% CI)	P-value
	Chinese (n = 19,033)	Non-Chinese (n = 57,099)	Hazard Ratio (95% CI)	P-value
Rhabdomyolysis ^*	16 (6.6)	79 (12.8)	0.61 (0.28 to 1.34)	0.22
Incident diabetes ^†	182 (267.5)	475 (252.4)	1.02 (0.80 to 1.30)	0.89
Acute kidney injury ^*	215 (89.2)	556 (90.8)	0.90 (0.72 to 1.13)	0.36
All-cause mortality ^‡	324 (133.5)	965 (156.4)	0.88 (0.74 to 1.05)	0.17

Abbreviations: confidence interval (CI)

* Outcomes assessed with hospital diagnosis codes. This underestimates the true event rate because these codes have high specificity but low sensitivity.

† Diabetes diagnoses assessed with the Ontario Diabetes Database; only matched sets where none of the users had evidence of baseline diabetes were included in this analysis (6,170 Chinese, 18,510 non-Chinese).

‡ All-cause mortality assessed with vital status field of Registered Persons Database of Ontario.